​

Funding Round

Private Equity Round - Bluesight

Private Equity Round - Bluesight

Investment Firm

Overview

Bluesight is a medication intelligence company that utilizes AI and machine learning to reduce risks and solve supply chain inefficiencies.

Announced Date

Jul 17, 2023

Closed on Date

Jul 17, 2023

Funding Type

Private Equity

Highlights

Location

United States, North America

Social

Investor Lead

Thoma Bravo

Thoma Bravo

Thoma Bravo is a early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed and venture firm.

Participant Investors

1

Investor Name
Participant InvestorThoma Bravo

Round Details and Background

Bluesight raised an undisclosed amount on 2023-07-17 in Private Equity Round

Bluesight is a medication intelligence company that utilizes AI and machine learning to reduce risks and solve supply chain inefficiencies.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 20, 2016
Series C - Bluesight
9-20.4M
Jan 12, 2015
Series B - Bluesight
7-12.0M
Jun 28, 2013
Series A - Bluesight
5-10.4M
Oct 01, 2012
Seed Round - Bluesight
5-100.0K

Recent Activity

There is no recent news or activity for this profile.